Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association
As early and effective antiretroviral therapy has become more widespread, HIV has
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …
Early remdesivir to prevent progression to severe Covid-19 in outpatients
RL Gottlieb, CE Vaca, R Paredes, J Mera… - … England Journal of …, 2022 - Mass Medical Soc
Background Remdesivir improves clinical outcomes in patients hospitalized with moderate-
to-severe coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in …
to-severe coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in …
KDIGO 2021 clinical practice guideline for the management of glomerular diseases
BH Rovin, SG Adler, J Barratt, F Bridoux… - Kidney …, 2021 - kidney-international.org
Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
Background Data on vaccine immunogenicity against SARS-CoV-2 are needed for the 40
million people globally living with HIV who might have less functional immunity and more …
million people globally living with HIV who might have less functional immunity and more …
Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000-2016
JL Marcus, WA Leyden, SE Alexeeff… - JAMA network …, 2020 - jamanetwork.com
Importance Antiretroviral therapy (ART) has improved life expectancy for individuals with HIV
infection, but recent data comparing life span and comorbidity-free years by HIV status are …
infection, but recent data comparing life span and comorbidity-free years by HIV status are …
Primary care guidance for persons with human immunodeficiency virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America
MA Thompson, MA Horberg, AL Agwu… - Clinical infectious …, 2021 - academic.oup.com
Advances in antiretroviral therapy (ART) have made it possible for persons with human
immunodeficiency virus (HIV) to live a near expected life span, without progressing to AIDS …
immunodeficiency virus (HIV) to live a near expected life span, without progressing to AIDS …
Outcomes of coronavirus disease 2019 (COVID-19) related hospitalization among people with human immunodeficiency virus (HIV) in the ISARIC World Health …
AM Geretti, AJ Stockdale, SH Kelly… - Clinical Infectious …, 2021 - academic.oup.com
Background Evidence is conflicting about how human immunodeficiency virus (HIV)
modulates coronavirus disease 2019 (COVID-19). We compared the presentation …
modulates coronavirus disease 2019 (COVID-19). We compared the presentation …
Atualização da diretriz brasileira de dislipidemias e prevenção da aterosclerose–2017
AA Faludi, MCO Izar, JFK Saraiva… - Arquivos brasileiros de …, 2017 - SciELO Brasil
Material de distribuição exclusiva à classe médica. Os Arquivos Brasileiros de Cardiologia
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
Background Health care for people living with HIV has improved substantially in the past two
decades. Robust estimates of how these improvements have affected prognosis and life …
decades. Robust estimates of how these improvements have affected prognosis and life …